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Introduction 
Despite advances in the treatment of abdominal aortic 
aneurysms (AAAs), the pathogenesis of aneurysmal 
disease remains obscure. Aneurysm screening pro- 
grammes have successfully identified a proportion of 
patients with early or small aortic aneurysms, ~-3 who 
do not fulfil the current criteria for elective aneurysm 
repair on the basis of aortic diameter. 4 At present these 
patients are managed conservatively, with regular 
ultrasonographic follow-up, but with increased 
knowledge of aneurysm pathophysiology, it is possi- 
ble that aneurysm growth may be retarded with 
medical or gene therapy. 5 This review presents the 
current theories of aneurysm pathogenesis, with 
emphasis on the cellular and biochemical events 
within this disease process. 
Histology of Abdominal Aortic Aneurysms 
The ability of the aorta to counter the force exerted by 
the blood is dependent on the structural proteins of 
the arterial wall. 6 Collagen and elastin are the pre- 
dominant proteins within the aorta, which act to 
uniformly distribute stresses within the tissue, and 
maintain an appropriate viscoelastic response to pul- 
satile oscillation. Smooth muscle cells (SMCs) are the 
major cell type, 7 and together with adventitial fibro- 
blasts, have the capacity to synthesis all components 
of the extracellular matrix (ECM). 
In the normal infrarenal aorta, the media is 
arranged in a series of well-defined concentric elastic 
lamellae. Each layer, bounded by relatively thick 
elastin bands, contains circumferentially oriented col- 
lagen fibres, along with a network of fine elastin fibres, 
and a layer of SMCs compacted between adjacent 
elastic lamellae. The close association of elastin, 
collagen, and SMCs in the aortic media is responsible 
for the viscoelastic properties of the adult aorta. 8
Abdominal aortic aneurysms are characterised by 
degeneration, destruction, and remodelling of the 
aortic wall. Aneurysmal dilatation is accompanied by 
an overall thickening of the aortic intima and adven- 
titia, with a marked loss of elastin from the tunica 
media, 6 and a ubiquitous chronic inflammatory 
infiltrate .9 
Composition of the Extracellular Matrix 
The expansion of infrarenal AAAs is accompanied by 
an increase in total protein, microfibrillar protein, and 
collagen content, together with a marked reduction in 
elastin concentration, and medial smooth muscle cell 
number. 6'9-~2 Sumner et al. ~3 were the first to docu- 
ment depletion of elastin in aneurysmal tissue, and 
numerous ubsequent biochemical studies have con- 
firmed this finding. 1~34-~6 The total elastin concentra- 
tion of infrarenal AAAs has been reported to be only 
5--8%, 14'17 when compared to the 15-35% of age- 
matched aortas. However, relative changes in elastin 
concentration may be misleading. Due to the concomi- 
tant increase in wall thickness with increasing aneu- 
rysm circumference, 12 elastin content, as opposed to 
concentration, has been shown to increase in AAA 
tissue. Nevertheless due to the increased total protein 
content in the aneurysmal orta, the elastin concentra- 
tion actually decreases. 1°'12'13 
The fibrillar collagen network provides most of the 
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tensile strength of the aortic wall. This network 
contains predominantly t pe I and III collagen 14 with 
the tensile characteristics being attributed to type III. 18 
Collagen is the principle component of the adventitia 
of any AAA, regardless of size. The relative collagen 
concentration, and absolute collagen content of the 
aneurysmal aorta have been demonstrated to be 
elevated in several studies. Minion et al. ~2 and Baxter 
et al. 1° found a five-fold and three-fold increase in 
collagen content respectively, whilst Menashi e~ al. is 
showed an increase in collagen concentration from 62 
to 84% in aneurysmal vs. control aortic tissue. 
There appears to be a correlation between increas- 
ing aneurysm size and collagen content, 12 which 
suggests a causal relationship between collagen syn- 
thesis and aortic dilatation. This relationship may be a 
compensatory esponse to increased wall stress, 19 as 
stretch is known to be a stimulus for connective tissue 
synthesis. 2° McGee et a lY  suggested that collagen 
synthesis and deposition was accelerated in the walls 
of unruptured aneurysms, as mRNA levels for 
a 1-procollagen were increased in AAA tissue extracts. 
Since elastin gene expression is unaltered in the wall 
of aortic aneurysms, 22these data suggest hat dis- 
cordant gene expression may contribute to the relative 
decrease in elastin concentration i aortic aneurysms. 
Others have argued that since the ratio of type I to 
type III collagen is unchanged in comparison to 
normal aorta, 18 selective degradation of elastin in the 
aneurysmal media would give an apparent dilutional 
increase in collagen concentration. It seems likely that 
a combination of increased collagen synthesis, and 
enhanced elastin degradation are responsible for the 
changes in matrix composition in the walls of AAAs. 
Interestingly, the matrix abnormalities demonstra- 
ble in AAAs are not confined solely to the aneurysmal 
segment, but are also found in aortic tissue proximal 
to the aneurysmal site. z° Ward 23 also demonstrated 
that mean diameters for the carotid, femoral brachial 
and popliteal arteries were significantly greater in 
patients with aortic aneurysms than in controls, 
suggesting that infrarenal aneurysmal disease may be 
a localised manifestation of a systemic dilating 
process. 
In addition to elastin, collagen, and SMCs, the 
medial elastic lamellae are associated with micro- 
fibrillar proteins, a family of glycoproteins defined by 
their proximity to amorphous elastin and their fibre 
diameter on electron microscopy. Several biochemical 
studies of aneurysmal tissue have shown an increase 
in content of approximately 20% of an unknown 
connective tissue protein, most likely to be a micro- 
fibrillar protein such as flbrillin. 16 The reasons for the 
increase in this unknown microfibrillar protein are 
currently unclear. 
The increased turnover of extracellular matrix com- 
ponents observed in the aneurysmal orta, results in a 
relative imbalance in structural proteins. It is not 
known whether this imbalance is an important aetio- 
logical factor in aneurysm formation, or whether it 
results from changes uch as wall tension and chronic 
inflammation. However, it is probable that the abnor- 
mal mechanical properties of AAAs are due to a 
decrease in the ratio of elastin to collagen, resulting in 
a functionally compromised aortic wall. 
Genetic Susceptibility 
Aortic fragility and rupture have been associated with 
inheritable mutations in two of the connective tissue 
components of the aortic wall, namely fibrillin in 
Marfan's syndrome, 24 and type III collagen in Ehlers- 
Danlos type IV disease. 25 However, these congenital 
diseases represent distinct clinical entities which do 
not often manifest as true AAAs. 
The first report of familial aggregation of AAAs 
without any known hereditary connective tissue 
disorder, was presented by Clifton in 1977. 26 This 
report described three siblings in a family with 
ruptured AAAs. Since then many epidemiological 
reports have been published demonstrating a higher 
than normal incidence of blood-relatives affected with 
AAAs. These data demonstrated the existence of a 
hereditary component predisposing to AAA forma- 
tion, which provided the impetus for genetic studies 
into AAA disease. 
To address the question of whether a single identifi- 
able locus accounts for the observed familial cluster- 
ing, several studies have utilised segregation analysis 
to examine multigenerational pedigrees. Majumber et 
al. 27 suggested that the pattern of inheritance observed 
in 91 families could be explained by a major autoso- 
mal diallelic locus with the aneurysmal allele being 
recessive. In contrast, Verloes et al. 28 examined 313 
pedigrees and concluded that the major genetic defect 
was a dominant rait with age-dependent penetrance. 
Differences in methodology may account for the 
discrepancy in the mode of inheritance between these 
two studies, but both series support he concept of a 
genetic element in aneurysm pathogenesis. 
There are several mechanisms by which genetic 
variables may predispose to AAA development. 
Increased enzymatic destruction of matrix compo- 
nents might result in arterial dilatation and studies on 
1-antitrypsin seemed initially to lend weight to this 
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hypothesis. 29Serine proteinases are inhibited predom- 
inantly by ct 1-antitrypsin, a deficiency of which is 
associated with emphysema and accelerated destruc- 
tion of elastic tissue in the lung. Chronic pulmonary 
disease has been considered to predispose patients 
with AAA to rupture. 3° Cohen et al. 29 initially 
described that the poorly inhibitory MZ R 1-anti- 
trypsin phenotype was found with increased fre- 
quency in patients with AAA. However this associa- 
tion has not been confirmed, and several larger studies 
have now demonstrated that the MZ and ZZ R 1-anti- 
trypsin phenotype are not related to aneurysmal 
disease. 31"32 Moreover, 85% ofpatients with AAA have 
the common MM phenotype. 29
Alternatively, inherited defects in elastin and colla- 
gen might result in an aortic media more prone to 
enzymatic degradation. Genetic variation in the elas- 
tin gene is negligible and has not been demonstrated 
in patients with AAA. 6 However, indirect evidence 
implicating the involvement of different collagen 
genotypes, resulted from the observation that some 
patients with cerebral aneurysms also appeared to 
have impaired synthesis of type III collagen. 33 A single 
base mutation Gly - -  Arg, at position 619 in the 
coding gene for type III collagen has subsequently 
been associated with AAA disease in a single family in 
the U.S.A., 34 although as with Ehlers-Danlos syn- 
drome, these patients had aortic dissections rather 
than true aneurysms. Surprisingly, this anomaly had 
little effect before the fourth to sixth decade of life, and 
has not been identified in other patients presenting 
with abdominal aneurysms. 35
One recent study by Powell et al. 35 found a specific 
polymorphism in the type III collagen gene, detected 
with the restriction enzyme Ava II, to be associated 
with AAA. This result may be significant, since the 
elastin content of the aortic media decreases in 
aneurysmal disease, thereby shifting the mechanical 
load of the pulse pressure from elastin to collagen. 15 In 
this situation subtle variations in the structure of type 
III collagen could influence the mechanical properties 
of the aorta. It was concluded that a genetic influence 
may determine whether, in the presence of athero- 
sclerotic risk factors, the aorta stenoses or dilates and 
might also determine how rapidly an aneurysm 
grows, since the polymorphic variation observed was 
proportional to aneurysm diameter. However, a recent 
study using detailed DNA sequencing of the triple 
helical domain of type III procollagen demonstrated 
that mutations in type III collagen are the cause of 
only 2% of aortic aneurysms. 36
On balance, it seems likely that inheritance of AAA 
disease is multifactorial, 37involving a complex inter- 
action between environmental influences and a con- 
stitutional genetic susceptibility. 14 Although the famil- 
ia l  clustering of AAA indicates a hereditary 
component and several candidate genes have been 
investigated, the precise genetic basis of aneurysm 
formation remains obscure. 
Haemodynamic Influences 
The tensile strength of the aortic wall results from the 
concentric arrangement of the medial elastic lamellae. 
The infrarenal aorta contains fewer elastic lamellae in 
contrast with the thoracic aorta, 8 which results in a 
relative deficiency of elastin, and a stiffer less com- 
pliant vessel. Superimposed upon this is a natural age- 
related decrease in the distensibility and elasticity of 
the aorta, owing to the effects of haemodynamic stress 
imparted 'during the cardiac cycle. 38 
Aortic aneurysms appear to have a predilection for 
the infrarenal aorta, and it has been suggested that this 
may be due to the unique haemodynamic conditions 
that characterise this region. 39 As the aorta descends 
from thorax to abdomen, it tapers and becomes less 
compliant. This has the effect of increasing the pulse 
pressure which becomes maximal in the infrarenal 
aorta. 4° In addition, pressure waves are reflected from 
the aortic bifurcation, which may contribute to loc- 
alised regions of increased pressure in the infrarenal 
aorta. An interesting example of this haemodynamic 
effect was noted in a study of amputees which 
resulted in an asymmetric flow pattern at the aortic 
bifurcation and an increased risk of aortic aneu- 
rysms. 41 Recent improvements in magnetic resonance 
imaging have also allowed blood velocity j~rofiles to 
be calculated in the normal aorta. Oyre et al.~!reported 
that peak wall shear stress is lower in the infrarenal 
than suprarenal aorta and that the magnitude and 
duration of negative shear stress is higher at the 
posterior than anterior wall in the infrarenal 
segment. 
Although the infrarenal aorta is associated with 
high pulse pressure and low shear stress, the haemo- 
dynamic conditions become increasingly deranged 
with aortic dilatation. Bluth et al. 43 validated early 
experimental studies 44'45 by  demonstrating that 
abdominal aneurysms may exhibit both laminar and 
turbulent flow in vivo. At low flow rates, the flow is 
laminar with a core of swiftly moving fluid being 
surrounded by an annulus of slower moving fluid 
circulating as a rotating vor tex .  46"47 Low et al. 48 
confirmed these observations and showed that intra- 
aneurysmal flow is slow compared with the non- 
dilated vessel and that stagnation of flow may occur in 
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the dome of the aneurysm. In contrast, at higher flow 
rates the flow becomes turbulent, 49and the threshold 
Reynolds number determining turbulence is reduced 
as the aneurysm expands. 5°These observations have 
important implications for shear stress within aortic 
aneurysms. In small aneurysms, laminar flow may 
predominate, and the resulting shear stress is lower 
than recorded in the normal calibre vessel and may 
even become negative. However, in larger aneurysms, 
the likelihood of turbulent flow is greater, and in 
turbulence, the peak shear stress will be much greater 
than in the non-dilated vessel. 5° 
Systemic and Localised Proteolysis 
The normal vascular ECM is a complex network of 
proteins and proteoglycans which exist in a state of 
constant flux. Homeostasis within the ECM is 
achieved by an intricate balance between synthesis 
and degradation of the matrix proteins, orchestrated 
by the resident mesenchymal cells. The physiological 
maintenance of tissue integrity involves the inter- 
action of numerous degradative nzymes and their 
inhibitors. The family of enzymes that selectively 
digest the components of the ECM are collectively 
called the matrix metalloproteinases (MMPs), since 
their catalytic mechanism depends on the presence of 
zinc at the active site. 5~ The MMPs belong to three 
main groups according to their substrate specificity: 
the collagenases, the gelatinases, and the stromelysins 
(Table 1). The proteinase activity of MMPs is inhibited 
under physiological conditions by the endogenous 
family of tissue inhibitors of metalloproteinases 
(TIMP-1,2, and 3). 51 
The enzymatic activity of the MMPs is tightly 
regulated at several levels. Many growth factors, 
cytokines, hormones, or tumour promoters regulate 
MMP expression at the transcriptional level. All these 
enzymes are secreted as inactive zymogens, which 
require proteolytic cleavage by other proteinases ( uch 
as plasmin, trypsin and even other MMPs) to exert 
their matrix-degrading potential. The balance between 
MMPs and their natural inhibitors, further modulates 
the enzymatic activity of the matrix degrading 
proteinsY 
Pathological changes in tissue integrity resulting 
from proteolytic processes are of central importance 
during the arterial degradation that accompanies 
aneurysm formation. Many studies employing sophis- 
ticated enzymatic assays have reported increased 
elastase, collagenase, and gelatinase activities within 
the aneurysmal ortic wall. 5z-ss 
Table 1. Names and molecular weights (secreted and active form) 
of several well-characterised matrix metalloproteinases (MMPs) 
and their inhibitors (TIMPs). 
Molecular 
Metalloproteinase Other names weight (kDa) 
MMP-1 Interstitial collagenase 52 secreted 
42 active 
MMP-2 72 kDa Gelatinase, 72 secreted 
Gelath~ase-A 66 active 
MMP-3 Stromelysin-1 57 secreted 
48 active 
MMP-7 Uterine metalloproteinase, 28 secreted 
PUMP-l, Matrilysin 19 active 
MMP-8 Neutrophil collagenase 85 secreted 
65 active 
MMP-9 92 kDa Gelatinase, 92 secreted 
Gelatinase-B 84 active 
MMP-10 Stromelysin-2 53 secreted 
47 active 
MMP-11  Stromelysin-3 51 secreted 
44 active 
MMP-14 MT-MMP-1 60 membrane 
bound 
MMP-15 MT-MMP-2 
TIMP-1 TIMP-1 29 secreted/ 
active 
TIMP-2 TIMP-2 20 secreted/ 
active 
In separate studies, Busuttil et al., 54 and Cannon and 
Read 59 reported increased elastase activity in aneur- 
ysmal disease. Subsequent reports, 52'53'6° speculated 
that this elastase activity was attributable to a serine 
proteinase, possibly circulating pancreatic elastase, 53
59 or leucocyte lastase. Indeed, the activity of serine 
proteinases have been extensively utilised in experi- 
mental animal models, with the direct infusion of 
elastase into cross-clamped segments of rat aorta 
resulting in aneurysm-like dilatation. 61'62 
However, subsequent data, 63 suggested that the 
increased elastase activity was due to a non-serine 
proteinase. In 1987, Campa et al. 15 described a 90 kDa 
proteinase that discriminated between aneurysmal 
and atherosclerotic tissue. This elastase belonged to 
the metalloproteinase rather than the serine proteinase 
family, as it did not cross-react with antibody to 
circulating leucocyte elastase, and it possessed an 
inhibitory profile consistent with an MMP. ~5 In 1991, 
64 • . .  Brophy et al. Identified an elastolytic proteinase in 
AAA tissue using substrate gel enzymography which 
had a molecular weight of approximately 80 kDa, in 
contrast to neutrophil and pancreatic elastases, which 
have a MW of 30 kDa.  64 
Recent work 56-5s has proven overwhelmingly that 
the elastases involved in aneurysmal tissue are mem- 
bers of the metalloproteinase family. Vine and 
Powel156 found the elastolytic activity of AAA tissue 
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specimens to be significantly increased when com- 
pared with homogenates from either atherosclerotic or
normal aorta, with the principal enzyme observed 
being an MMP with a molecular mass of 92 kDa. 56 
They concluded that this enzyme was consistent with 
the latent form of MMP-9. 56 In 1994, two major studies 
by Newman et al. 57'5s used substrate gel electro- 
phoresis to compare AAA tissue extracts with age- 
matched controls. Both studies observed a band of 
activity at 80 kDa which was demonstrated to be the 
active isoform of MMP-9 by immunoblotting. On the 
basis of these observations and the known elastolytic 
properties of MMP 9, 65 this proteinase is believed to 
play a central role in aneurysm pathogenesis. 
Interest in the role of interstitial collagenase (MMP- 
1) in AAAs was initiated by Busuttil et al. 55 Vine and 
Powel156 found considerable MMP-1 activity in aneur- 
ysmal aortas, whilst Irizarry et al. 66 demonstrated that 
AAA extracts contained increased amounts of mate- 
rial immunoreactive to MMP-1. However, Herron et 
al. 52 were unable to immunoprecipitate MMP-1 from 
either aneurysmal or normal aortic extracts, and 
Webster et al. 67 likewise found it impossible to extract 
active interstitial collagenase under non-reducing con- 
ditions. It has been suggested 6sthat these conflicting 
results were due to the binding of MMP-1 to its 
natural inhibitor, TIMP-1, which may mask its detec- 
tion in activity assays. Irizarry et al. 66 resolved this 
problem by running immunoblots after polyacryla- 
mide gel electrophoresis under reduced conditions. 
Immunoreactive bands of AAA extracts to the MMP-1 
antibody were subsequently detected, whereas control 
extracts had little or no levels of immunoreactive 
material. 
Stromelysin-1 (MMP-3) has also been implicated in 
the destruction of the aortic matrix during aneurysm 
formation, both directly 51'69 and through indirect 
activation of MMPs-1 and 9. 70 In examining homoge- 
nates from aneurysmal aortic media, Vine and 
Powel156 reported increased levels of MMP-3, a find- 
ing which has been confirmed by other investiga- 
tors. s7'58 The results of investigations into enzymatic 
activity within the aortic wall suggest hat MMPs-I,3, 
and 9 are significantly elevated in aneurysmal tissue 
when compared to atherosclerotic controls. Recently, 
Freestone t al. 71 demonstrated that MMP-2 was the 
dominant proteolytic enzyme in small aortic aneu- 
rysms, whereas in larger vessels with a pronounced 
inflammatory infiltrate, MMP-9 was the principle 
gelatinase. 
Whilst an over activity of MMPs may explain the 
proteolytic degradation observed in AAAs, a contribu- 
tory role of a deficiency in the natural anti-proteolytic 
system has also been postulated. Recent investigations 
by Brophy et al. 72 have shown that TIMP-1 is 
decreased in AAA tissue, although this does not 
appear to be a result of a primary genetic defect. 73 
Although Newman et al. 57"5s were able to con- 
clusively prove that the N 80 kDa proteinase isolated 
from AAA homogenates contained active MMP-9, 
they also observed that a portion of the 80 kDa activity 
could not be bound to a recombinant-TIMP-1 affinity 
column. This activity was inhibited by a serine 
proteinase inhibitor, suggesting that some of the 
activity demonstrated in the tissue extracts was not 
MMP-9, but serine proteinase. Studies by Jean-Claude 
et al. 74 conclusively demonstrated the presence of 
plasmin in AAA extracts, whilst Reilly et al. 75 found 
levels of tissue-type plasminogen activator to be 
abundant in AAA tissue by comparison with normal 
or atherosclerotic aorta. These results appear to be 
important, as plasmin itself can degrade the ECM, but 
has also been shown to activate latent pro-MMP-1, 
pro-MMP-3, and pro-MMP-9. 76 The presence of plas- 
min in the aneurysm wall suggests that it may play an 
important role in the overall cascade of enzyme 
activation. 
The synergistic actions of the MMPs present in 
elevated levels in AAA tissue could both initiate and 
maintain the ECM degradation observed in the aneur- 
ysmal aortic media. The 92 kDa gelatinase is not only 
capable of degrading elastin 6s'77 but can also degrade 
denatured collagen, thus facilitating the action of 
interstitial collagenase on native type I and type III 
collagens, which are major constituents of the vascular 
wall. 14 In addition" " , Okada et al.69 have reported that 
MMP-9 may degrade native fibrillar collagens, which 
are also reduced in the aneurysm wall. The presence of 
active forms of MMP-3, and plasmin, suggest a 
cascade of events leading to activated forms of both 
MMP-1 and MMP-9 that could then result in the 
concerted egradation of elastin, fibrillar collagens, 
and other ECM components in the vascular wall, 
during aneurysm developmental nd progression, s7
The Role of Inflammation 
Abdominal aortic aneurysms are typically charac- 
terised by a marked chronic inflammatory infiltrate of 
varying intensity throughout he aortic wall. 9'58'78'79 
These cells have been purported to play a significant 
role in the destruction of the extracellular matrix, both 
directly, and through cytokinetic paracrine control of 
the native aortic mesenchymal cells. 
Koch et al. 9 demonstrated that the majority of 
inflammatory cells in the aneurysmal orta were CD3 ÷ 
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T-lymphocytes, which were found predominately in 
the advenfitia. A CD19 ÷ B-lymphocyte component 
was also prominent, with the remainder of the 
inflammatory cells being CD11c + macrophages. The 
aggregating lymphocytes were often found in clusters, 
with B-cells surrounded by CD3 + T-cells, often located 
around the adventitial vasa vasorum. Macrophages 
were also found scattered within these lymphoid 
aggregates. 
Components of the inflammatory infiltrate have the 
potential to secrete all the MMPs responsible for ECM 
degradation, and the participation of inflammatory 
cells in the genesis of AAAs was suggested by Vine 
and Powell, 56 who demonstrated a positive correlation 
between elastolytic activity and the presence of white 
cell infiltration. Macrophages are known to produce 
an array of degradative proteinases. Shapiro et al. 8° 
have shown that as monocytes migrate into tissue and 
differentiate into macrophages, their potential to 
secrete serine proteinases ceases, while gene expres- 
sion for a variety of MMPs, including MMP-1, MMP-3 
and MMP-9 increases dramatically. 
A recent immunohistochemical study attempted to 
delineate the in situ source of the enzymes present in 
AAA tissue using specific monoclonal antibodies, l 
This study identified the infiltrating inflammatory 
cells, specifically the CD14 + macrophage, to be 
responsible for the delivery of two of the MMPs 
present, namely MMP-3 and MMP-9. 
In addition to the direct destruction of the ECM by 
MMP secretion, the infiltrating macrophages and 
lymphocytes may be important in activating resident 
mesenchymal cells 7 through cytokinetic control mech- 
anisms. A number of cytokines have been shown to be 
significantly increased in homogenates and explants 
from the aneurysmal ortic wall, e.g. tumour necrosis 
factor-c~ (TNF-~), 82 interleukin-l~ (IL-I~), s2 interleu- 
kin-6 (IL-6), 83 interferon-gamma (IFN-y), 83 monocyte 
84 chemoattractant protein-1 (MCP-1) and interleukin-8 
(IL-8). s4 
Interleukin-l~ is secreted by B cells, endothelial 
85 cells, and fibroblasts, although the principle source is 
from stimulated macrophages. Positive-feedback 
involving the resident vascular cells may act locally to 
amplify and propagate the inflammatory eaction, 86 as 
IL-I~ is a versatile cytokine which exerts biological 
effects on resident endothelial and smooth muscle 
cells. 87 Elias et al. s8 demonstrated IL-lO to induce 
collagen synthesis in mesenchymal cells, which may 
partly explain the increase in collagen content 
reported by numerous biochemical studies on the 
aneurysmal ortic wall. 
Tumour necrosis factor-ct is a 17 kDa protein 
secreted primarily by activated macrophagesY 
although other cells, including lymphocytes and 
vascular smooth muscle cells, may produce it. 89'9° 
TNF-~ induces its own gene expression in vascular 
smooth muscle cells 9° and significant levels of TNF-~ 
have also been detected in homogenates of aneur- 
ysmal aortas. 82 In addition to its other inflammatory 
actions, TNF-R has been shown to be angiogenic, 
stimulating endothelial cell growth and prolifera- 
tion. 91 Recentl~ Holmes et al. 92 demonstrated that 
abdominal aneurysms exhibited a marked angiogenic 
response in comparison to normal or atherosclerotic 
aortic tissue. This has significant implications, as 
neovascularisation is associated with an elevated 
production of MMPs and a marked inflammatory 
response, 93 which may exacerbate matrix 
degradation. 
Interleukin-l~ and TNF-ct can induce the expression 
of endothelial cell adhesion molecules. 94Davis et al. 95 
localised a significant increase in intercellular adhe- 
sion molecule-1 (ICAM-1), to the endothelial cells of 
the vasa vasorum in aneurysmal tissue, suggesting 
recruitment of monocytes and other inflammatory 
cells by means of the adventitial vasa. This induction 
of ICAM-1 expression on the endothelial cells of the 
vasa vasorum may induce a permissive state in which 
mononuclear cells enter the adventitial matrix. Once 
in place, aortic tissue macrophages may further 
stimulate the expression of ICAM-1 via IL-I~ and 
TNF-~, which then enhance the attraction of addi- 
tional inflammatory cells to the arterial wall. While et 
al. 19 have suggested that destruction of adventitial 
elastin may play a primary role in the pathogenesis of 
AAA formation, and may result from the recruitment 
of inflammatory cells by ICAM-1 expression and 
neovascularisation. 
Szekanecz et al. 83 revealed a significant increase in 
IL-6 and IFN-y production by AAA tissue. Interleukin- 
6 is mainly produced by macrophages 96 and is 
predominately involved with T- and B-lymphocyte 
activation during inflammation, s3 The accumulation 
of immunoglobulin aneurysmal walls may be the 
result of increased local levels of IL-6. 7s Interferon-• 
has the ability to both stimulate lymphocytes and 
induce MHC class II antigen expression in smooth 
muscle and endothelial cells. The enhanced levels of 
IL-6 and IFN-y in AAA tissue strongly suggest hat 
they play an important regulatory role in the ongoing 
active immune response seen within aneurysmal 
tissue. 
While it seems possible that aneurysmal dilatation 
partially represents an immune-mediated disease, the 
signals that initially attract leucocytes into the tissue 
remain obscure. Analogies have been drawn between 
the processes involved in aneurysm formation and 
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those involved in other pathologies. 9 Cid et al. 97 have 
postulated that the putative antigenic substance 
responsible for temporal arteritis might be an inert 
substance, such as elastin derived peptides. In the 
aneurysm wall, elastin could potentially degenerate 
and have its structure altered by the ageing process, or 
its degradation could be initiated by some proteolytic 
imbalance defined by a genetic predisposition. The 
generation of elastin derived peptides may then 
initiate aneurysm genesis through attraction of white 
cells and induction of MMP production from mesen- 
chymal cells in the arterial wall. 98'99 
Several studies have demonstrated that cytokines 
derived from the inflammatory infiltrate may influ- 
ence the expression of MMPs at the transcriptional 
level, z°° Keen et al. ~°1 cultured smooth muscle cell 
explants from human aneurysmal tissue with IL-lfi, 
and demonstrated a ose-dependent i crease in inter- 
stitial collagenase gene expression. More importantly, 
Newman et al. 81 observed that MMP-1 could be 
localised to mesenchymal cells in the aneurysm wall 
suggesting that both white cells and mesenchymal 
cells may act as sources of MMPs in vivo. In addition, 
Galis et al. 7 showed that smooth muscle cell secretion 
of MMPs -1, -2, -3 and -9 followed stimulation with 
IL-lfi or TNF-cz, and that whilst SMCs stimulated with 
cytokines expressed several MMPs, mRNA and pro- 
tein levels of TIMPs 1 and 2 appeared unaffected. 
These data further support he concept that cytokines 
may alter the balance between matrix degradation and 
synthesis. 
Although SMCs, fibroblasts, and macrophages can 
all potentially produce interstitial collagenase in vitro, 
the capacity for mesenchymal cells to produce MMP-1 
appears to be much greater than that found in 
macrophagesJ °1 Welgus et al. 1°~" observed that stimu- 
lated fibroblasts produced sixfold greater amounts of 
collagenase than an equal number of stimulated 
macrophages. The observation by Vine and Powel156 
that collagenase activity in aneurysms i greatest in 
the outer aspect of the media is consistent with the 
results obtained by Keen et aI. 1°1 and Newman et al., 81 
suggesting that the SMC is the source of the elevated 
collagenase found in AAAs. 
It appears likely that the cascade of events resulting 
in the destruction of the extracellular matrix is highly 
complex, with both cell-matrix and cell-cell inter- 
actions contributing to the processes in vivo. 82 The 
importance of the inflammatory cellular infiltrate 
found in aortic aneurysmal disease lies in both the 
potential paracrine modulation of adventitial endothe- 
lial and vascular smooth muscle cell function, and 
autocrine activation and recruitment of migrating 
leucocytes through the cytokine network. 86 
Atherosclerosis and Aneurysm Pathogenesis 
Abdominal aortic aneurysms have historically been 
classified as atherosclerotic in origin because of the 
almost universal finding of calcified atherosclerotic 
degeneration in the walls of aneurysmsJ 5 This 
assumed "causative" relationship isbased on common 
risk factors, 14'~°3 other regional manifestations of 
atherosclerosis, and localisation of aneurysms to the 
atherosclerosis~rone infrarenal aorta. 
Zarins et al. 1°4 were able to induce AAA formation 
in monkeys fed on a lipid-rich atherogenic diet. They 
found that five of 443 monkeys who experienced 
prolonged exposure to an atherogenic diet, and who 
were then transferred to a low cholesterol regimen 
developed aneurysms. They hypothesised that the 
development of fibrous tissue within atherosclerotic 
plaques provided structural support o the aortic wall, 
and that during the period of regression of the 
atherogenic diet, the plaques receded, removing the 
support hat these lesions provided which resulted in 
AAA formation. 
In contrast to the thoracic aorta, the infrarenal 
abdominal aorta contains relatively few vasa vasorum, 
with appropriate l vels of oxygenation and nutrition 
being provided by pressure filtration from the 
lumenJ °s This paucity of vasa has been suggested as a 
factor that may explain the particular propensity of 
the infrarenal segment of the human aorta to develop 
early and severe atherosclerosisJ °3 Consequently, 
advanced thickening of the intima by atherosclerotic 
lesions and thrombus could further impede the only 
source of nutrients to a faltering media, and theoret- 
ically exacerbate deterioration of the elastic and 
collagen architecture of the aortic wall  initiating 
aneurysm formation. 
However, it has also been argued that, aneurysms 
may become atherosclerotic as a secondary phenome- 
non, since atheromatous plaques are preferentially 
formed in regions of turbulence and low shear 
stressJ °6-1°9 Tilson 1°7 has also proposed that the 
effects of smoking and hypertension, risk factors in 
both atherosclerotic o clusive, and aneurysmal dis- 
ease, may mediate the promotion of either disease 
through unique disease-specific mechanisms, depend- 
ent on the constitutional susceptibilities to both 
diseases. 
Reports of familial clustering of aneurysmal dis- 
26 110 111 ease ' • has left little doubt that there must be an 
im ortant enetic susce tibili to AAA formation In P g 2 P ty 
addition, Ward 3 observed that AAA patients demon- 
strated systemicarterial di atation in peripheral arter- 
ies which are seldom, if ever, involved in athero- 
sclerosis. These findings add further support to the 
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view that aneurysmal disease has specific determi- 
nants that may be unrelated to the atherosclerotic 
process and distinguish it from occlusive disease as a 
unique pathogenic entity. 
The controversy surrounding the aetiological role 
that atherosclerosis plays in AAA formation necessi- 
tates further detailed studies on a molecular level to 
reveal precisely which disease is the prerequisite for 
the other. 
Summary and Future Prospects 
Abdominal aortic aneurysms are characterised by 
degradation and remodelling of the extracellular 
matrix. These changes derive from excessive protei- 
nase activity within the arterial wall which may result 
from, or cause a widespread inflammatory response. 
Despite the success in characterising the pathological 
characteristics of established abdominal aortic aneu- 
rysms, relatively little progress has been made in 
determining the initiating aetiological factors in this 
disease. Genetic components certainly play a role, but 
do not appear to be causative in all cases• Most studies 
investigating aneurysm pathogenesis have utilised 
tissue from established abdominal aneurysms. By 
definition, this tissue represents the end-stage of a 
pathological process, and it may be difficult to 
differentiate causative factors from secondary degen- 
erative changes. 
Further progress in elucidating the pathogenesis of 
abdominal aortic aneurysms is likely to result from 
studies attempting to identify abnormalities in gene 
expression• To separate cause from secondary effects, 
it may be necessary to culture individual cell lines 
from the aortic wall, whilst the use of animal models 
may allow specific cellular interactions to be studied• 
Knowledge of pathogenesis may allow therapeutic 
options for small aneurysms to be explored, and 
evidence has already begun to emerge that metal- 
loproteinase inhibitors may reduce the growth of 
experimental aneurysms. 
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